WEBVTT
Kind: captions
Language: en

00:00:00.020 --> 00:00:02.320 

I'm<00:00:00.710> involved<00:00:01.130> in<00:00:01.430> the<00:00:01.550> diagnosis<00:00:02.149> and

00:00:02.320 --> 00:00:02.330 
I'm involved in the diagnosis and

00:00:02.330 --> 00:00:03.550 
I'm involved in the diagnosis and
treatment<00:00:02.720> of<00:00:02.840> all<00:00:03.080> general

00:00:03.550 --> 00:00:03.560 
treatment of all general

00:00:03.560 --> 00:00:05.829 
treatment of all general
gastrointestinal<00:00:04.339> disorders<00:00:04.940> including

00:00:05.829 --> 00:00:05.839 
gastrointestinal disorders including

00:00:05.839 --> 00:00:08.020 
gastrointestinal disorders including
upper<00:00:06.230> and<00:00:06.440> lower<00:00:06.649> GI<00:00:06.919> tract<00:00:07.250> disease<00:00:07.609> liver

00:00:08.020 --> 00:00:08.030 
upper and lower GI tract disease liver

00:00:08.030 --> 00:00:10.720 
upper and lower GI tract disease liver
and<00:00:08.330> pancreatic<00:00:08.750> diseases<00:00:09.340> one<00:00:10.340> of<00:00:10.460> the<00:00:10.520> most

00:00:10.720 --> 00:00:10.730 
and pancreatic diseases one of the most

00:00:10.730 --> 00:00:12.340 
and pancreatic diseases one of the most
common<00:00:11.150> disorders<00:00:11.600> I<00:00:11.720> encounter<00:00:12.200> is

00:00:12.340 --> 00:00:12.350 
common disorders I encounter is

00:00:12.350 --> 00:00:15.119 
common disorders I encounter is
gastroesophageal<00:00:12.950> reflux<00:00:13.790> disease<00:00:13.910> or<00:00:14.420> GERD

00:00:15.119 --> 00:00:15.129 
gastroesophageal reflux disease or GERD

00:00:15.129 --> 00:00:17.890 
gastroesophageal reflux disease or GERD
most<00:00:16.129> patients<00:00:16.670> who<00:00:16.700> have<00:00:16.970> GERD<00:00:17.240> present<00:00:17.750> with

00:00:17.890 --> 00:00:17.900 
most patients who have GERD present with

00:00:17.900 --> 00:00:19.930 
most patients who have GERD present with
symptoms<00:00:17.930> such<00:00:18.560> as<00:00:18.590> Harper<00:00:19.160> regurgitation

00:00:19.930 --> 00:00:19.940 
symptoms such as Harper regurgitation

00:00:19.940 --> 00:00:23.440 
symptoms such as Harper regurgitation
and<00:00:20.150> or<00:00:20.570> chest<00:00:20.930> pain<00:00:21.820> repetitive<00:00:22.820> injury<00:00:23.270> to

00:00:23.440 --> 00:00:23.450 
and or chest pain repetitive injury to

00:00:23.450 --> 00:00:25.630 
and or chest pain repetitive injury to
the<00:00:23.570> esophagus<00:00:24.200> from<00:00:24.530> stomach<00:00:24.860> acids<00:00:25.400> can

00:00:25.630 --> 00:00:25.640 
the esophagus from stomach acids can

00:00:25.640 --> 00:00:27.810 
the esophagus from stomach acids can
lead<00:00:25.789> to<00:00:25.880> complications<00:00:26.110> related<00:00:27.110> to<00:00:27.260> guard

00:00:27.810 --> 00:00:27.820 
lead to complications related to guard

00:00:27.820 --> 00:00:30.220 
lead to complications related to guard
these<00:00:28.820> complications<00:00:29.480> can<00:00:29.810> include<00:00:29.869> things

00:00:30.220 --> 00:00:30.230 
these complications can include things

00:00:30.230 --> 00:00:33.040 
these complications can include things
such<00:00:30.680> as<00:00:30.910> esophagitis<00:00:31.910> or<00:00:32.180> inflammation<00:00:32.630> of

00:00:33.040 --> 00:00:33.050 
such as esophagitis or inflammation of

00:00:33.050 --> 00:00:36.010 
such as esophagitis or inflammation of
the<00:00:33.079> lining<00:00:33.290> of<00:00:33.530> the<00:00:33.560> esophagus<00:00:35.020> esophageal

00:00:36.010 --> 00:00:36.020 
the lining of the esophagus esophageal

00:00:36.020 --> 00:00:38.440 
the lining of the esophagus esophageal
strictures<00:00:36.560> or<00:00:36.800> narrowing<00:00:37.400> of<00:00:37.640> the<00:00:37.880> esophagus

00:00:38.440 --> 00:00:38.450 
strictures or narrowing of the esophagus

00:00:38.450 --> 00:00:40.330 
strictures or narrowing of the esophagus
or<00:00:38.630> condition<00:00:39.350> known<00:00:39.560> as<00:00:39.590> Barrett's

00:00:40.330 --> 00:00:40.340 
or condition known as Barrett's

00:00:40.340 --> 00:00:43.360 
or condition known as Barrett's
esophagus<00:00:41.380> I'm<00:00:42.380> going<00:00:42.829> to<00:00:42.920> focus<00:00:43.070> my

00:00:43.360 --> 00:00:43.370 
esophagus I'm going to focus my

00:00:43.370 --> 00:00:45.069 
esophagus I'm going to focus my
discussion<00:00:43.820> on<00:00:43.910> Barrett's<00:00:44.210> esophagus<00:00:44.750> today

00:00:45.069 --> 00:00:45.079 
discussion on Barrett's esophagus today

00:00:45.079 --> 00:00:47.170 
discussion on Barrett's esophagus today
because<00:00:45.530> this<00:00:45.770> is<00:00:46.010> a<00:00:46.040> very<00:00:46.460> important

00:00:47.170 --> 00:00:47.180 
because this is a very important

00:00:47.180 --> 00:00:50.080 
because this is a very important
complication<00:00:47.870> related<00:00:48.290> to<00:00:48.410> reflux<00:00:49.090> in

00:00:50.080 --> 00:00:50.090 
complication related to reflux in

00:00:50.090 --> 00:00:52.000 
complication related to reflux in
Barrett's<00:00:50.660> esophagus<00:00:51.260> the<00:00:51.469> lining<00:00:51.860> of<00:00:51.980> the

00:00:52.000 --> 00:00:52.010 
Barrett's esophagus the lining of the

00:00:52.010 --> 00:00:54.580 
Barrett's esophagus the lining of the
esophagus<00:00:52.309> changes<00:00:53.210> from<00:00:53.960> a<00:00:54.079> more<00:00:54.290> normal

00:00:54.580 --> 00:00:54.590 
esophagus changes from a more normal

00:00:54.590 --> 00:00:57.160 
esophagus changes from a more normal
esophageal<00:00:55.190> tissue<00:00:55.610> to<00:00:56.149> an<00:00:56.300> intestinal<00:00:56.930> type

00:00:57.160 --> 00:00:57.170 
esophageal tissue to an intestinal type

00:00:57.170 --> 00:00:59.979 
esophageal tissue to an intestinal type
of<00:00:57.350> tissue<00:00:57.760> this<00:00:58.760> change<00:00:59.239> increases<00:00:59.960> a

00:00:59.979 --> 00:00:59.989 
of tissue this change increases a

00:00:59.989 --> 00:01:03.729 
of tissue this change increases a
person's<00:01:00.230> risk<00:01:00.530> for<00:01:01.040> esophageal<00:01:01.610> cancers<00:01:02.739> any

00:01:03.729 --> 00:01:03.739 
person's risk for esophageal cancers any

00:01:03.739 --> 00:01:06.330 
person's risk for esophageal cancers any
patient<00:01:04.339> who<00:01:04.429> has<00:01:04.549> chronic<00:01:04.999> reflux<00:01:05.479> or

00:01:06.330 --> 00:01:06.340 
patient who has chronic reflux or

00:01:06.340 --> 00:01:08.800 
patient who has chronic reflux or
persistent<00:01:07.340> reflux<00:01:07.759> despite<00:01:08.209> treatment<00:01:08.479> or

00:01:08.800 --> 00:01:08.810 
persistent reflux despite treatment or

00:01:08.810 --> 00:01:10.749 
persistent reflux despite treatment or
any<00:01:09.079> person<00:01:09.350> who<00:01:09.679> has<00:01:09.709> alarmed<00:01:10.189> symptoms

00:01:10.749 --> 00:01:10.759 
any person who has alarmed symptoms

00:01:10.759 --> 00:01:13.059 
any person who has alarmed symptoms
associated<00:01:11.209> with<00:01:11.659> reflux<00:01:12.079> such<00:01:12.439> as<00:01:12.590> dysphasia

00:01:13.059 --> 00:01:13.069 
associated with reflux such as dysphasia

00:01:13.069 --> 00:01:14.999 
associated with reflux such as dysphasia
which<00:01:13.759> means<00:01:14.060> difficulty<00:01:14.630> swallowing

00:01:14.999 --> 00:01:15.009 
which means difficulty swallowing

00:01:15.009 --> 00:01:17.499 
which means difficulty swallowing
bleeding<00:01:16.009> or<00:01:16.219> weight<00:01:16.459> loss<00:01:16.670> should<00:01:17.209> undergo

00:01:17.499 --> 00:01:17.509 
bleeding or weight loss should undergo

00:01:17.509 --> 00:01:20.919 
bleeding or weight loss should undergo
an<00:01:17.719> upper<00:01:18.020> endoscopy<00:01:18.289> or<00:01:18.859> an<00:01:19.009> EGD<00:01:19.369> in<00:01:19.929> this

00:01:20.919 --> 00:01:20.929 
an upper endoscopy or an EGD in this

00:01:20.929 --> 00:01:22.929 
an upper endoscopy or an EGD in this
procedure<00:01:21.409> a<00:01:21.590> patient<00:01:22.039> is<00:01:22.130> sedated<00:01:22.639> and<00:01:22.759> a

00:01:22.929 --> 00:01:22.939 
procedure a patient is sedated and a

00:01:22.939 --> 00:01:24.760 
procedure a patient is sedated and a
small<00:01:23.240> flexible<00:01:23.749> tube<00:01:24.109> with<00:01:24.319> a<00:01:24.350> lightening

00:01:24.760 --> 00:01:24.770 
small flexible tube with a lightening

00:01:24.770 --> 00:01:27.190 
small flexible tube with a lightening
camera<00:01:25.159> at<00:01:25.340> the<00:01:25.850> end<00:01:26.029> of<00:01:26.149> it<00:01:26.329> is<00:01:26.509> inserted<00:01:27.079> into

00:01:27.190 --> 00:01:27.200 
camera at the end of it is inserted into

00:01:27.200 --> 00:01:29.800 
camera at the end of it is inserted into
the<00:01:27.319> patient's<00:01:27.829> mouth<00:01:28.009> it<00:01:28.340> is<00:01:29.060> directed<00:01:29.599> down

00:01:29.800 --> 00:01:29.810 
the patient's mouth it is directed down

00:01:29.810 --> 00:01:31.330 
the patient's mouth it is directed down
through<00:01:30.109> the<00:01:30.229> esophagus<00:01:30.499> into<00:01:31.069> the<00:01:31.219> stomach

00:01:31.330 --> 00:01:31.340 
through the esophagus into the stomach

00:01:31.340 --> 00:01:33.969 
through the esophagus into the stomach
into<00:01:31.909> this<00:01:32.209> middle<00:01:32.869> portion<00:01:33.259> of<00:01:33.409> the<00:01:33.679> small

00:01:33.969 --> 00:01:33.979 
into this middle portion of the small

00:01:33.979 --> 00:01:36.940 
into this middle portion of the small
intestine<00:01:34.810> during<00:01:35.810> this<00:01:35.929> procedure<00:01:36.139> the

00:01:36.940 --> 00:01:36.950 
intestine during this procedure the

00:01:36.950 --> 00:01:38.980 
intestine during this procedure the
lining<00:01:37.399> of<00:01:37.549> the<00:01:37.819> upper<00:01:38.090> GI<00:01:38.299> tract<00:01:38.630> can<00:01:38.840> be

00:01:38.980 --> 00:01:38.990 
lining of the upper GI tract can be

00:01:38.990 --> 00:01:41.459 
lining of the upper GI tract can be
evaluated<00:01:39.200> and<00:01:39.770> biopsies<00:01:40.219> can<00:01:40.429> be<00:01:40.549> obtained

00:01:41.459 --> 00:01:41.469 
evaluated and biopsies can be obtained

00:01:41.469 --> 00:01:43.510 
evaluated and biopsies can be obtained
during<00:01:42.469> this<00:01:42.649> procedure<00:01:42.889> Barrett's

00:01:43.510 --> 00:01:43.520 
during this procedure Barrett's

00:01:43.520 --> 00:01:46.569 
during this procedure Barrett's
esophagus<00:01:44.029> can<00:01:44.270> be<00:01:44.419> diagnosed<00:01:44.659> a<00:01:45.579> patient

00:01:46.569 --> 00:01:46.579 
esophagus can be diagnosed a patient

00:01:46.579 --> 00:01:48.300 
esophagus can be diagnosed a patient
diagnosed<00:01:47.060> with<00:01:47.299> barrett's<00:01:47.630> oesophagus

00:01:48.300 --> 00:01:48.310 
diagnosed with barrett's oesophagus

00:01:48.310 --> 00:01:50.859 
diagnosed with barrett's oesophagus
undergoes<00:01:49.310> treatment<00:01:49.340> basically<00:01:50.329> to<00:01:50.479> control

00:01:50.859 --> 00:01:50.869 
undergoes treatment basically to control

00:01:50.869 --> 00:01:53.379 
undergoes treatment basically to control
reflux<00:01:51.349> symptoms<00:01:51.849> the<00:01:52.849> mainstay<00:01:53.359> of

00:01:53.379 --> 00:01:53.389 
reflux symptoms the mainstay of

00:01:53.389 --> 00:01:55.539 
reflux symptoms the mainstay of
treatment<00:01:53.539> includes<00:01:54.380> both<00:01:54.770> dietary

00:01:55.539 --> 00:01:55.549 
treatment includes both dietary

00:01:55.549 --> 00:01:58.169 
treatment includes both dietary
modifications<00:01:56.359> as<00:01:56.539> well<00:01:56.929> as<00:01:57.049> medical<00:01:57.259> therapy

00:01:58.169 --> 00:01:58.179 
modifications as well as medical therapy

00:01:58.179 --> 00:02:00.580 
modifications as well as medical therapy
proton<00:01:59.179> pump<00:01:59.479> inhibitors<00:02:00.020> are<00:02:00.049> the<00:02:00.409> main

00:02:00.580 --> 00:02:00.590 
proton pump inhibitors are the main

00:02:00.590 --> 00:02:02.649 
proton pump inhibitors are the main
class<00:02:00.889> of<00:02:01.069> drugs<00:02:01.340> used<00:02:01.609> to<00:02:01.700> treat<00:02:01.789> gerd

00:02:02.649 --> 00:02:02.659 
class of drugs used to treat gerd

00:02:02.659 --> 00:02:05.559 
class of drugs used to treat gerd
related<00:02:03.139> Barrett's<00:02:03.469> esophagus<00:02:04.299> drugs<00:02:05.299> such

00:02:05.559 --> 00:02:05.569 
related Barrett's esophagus drugs such

00:02:05.569 --> 00:02:07.659 
related Barrett's esophagus drugs such
as<00:02:05.599> prilosec<00:02:06.139> omeprazole<00:02:06.349> are<00:02:07.189> two<00:02:07.429> of<00:02:07.579> the

00:02:07.659 --> 00:02:07.669 
as prilosec omeprazole are two of the

00:02:07.669 --> 00:02:09.910 
as prilosec omeprazole are two of the
many<00:02:07.880> drugs<00:02:08.180> in<00:02:08.360> this<00:02:08.509> class<00:02:08.840> which<00:02:09.619> lower

00:02:09.910 --> 00:02:09.920 
many drugs in this class which lower

00:02:09.920 --> 00:02:13.210 
many drugs in this class which lower
acid<00:02:10.520> levels<00:02:10.850> and<00:02:11.060> promote<00:02:11.990> healing<00:02:12.350> and

00:02:13.210 --> 00:02:13.220 
acid levels and promote healing and

00:02:13.220 --> 00:02:16.090 
acid levels and promote healing and
role<00:02:13.310> of<00:02:13.550> symptoms<00:02:14.140> any<00:02:15.140> patient<00:02:15.740> who<00:02:15.890> has

00:02:16.090 --> 00:02:16.100 
role of symptoms any patient who has

00:02:16.100 --> 00:02:17.650 
role of symptoms any patient who has
Barrett's<00:02:16.490> oesophagus<00:02:17.060> will<00:02:17.300> undergo

00:02:17.650 --> 00:02:17.660 
Barrett's oesophagus will undergo

00:02:17.660 --> 00:02:21.160 
Barrett's oesophagus will undergo
repeated<00:02:18.500> periodic<00:02:19.460> upper<00:02:19.820> endoscopies<00:02:20.170> to

00:02:21.160 --> 00:02:21.170 
repeated periodic upper endoscopies to

00:02:21.170 --> 00:02:23.980 
repeated periodic upper endoscopies to
look<00:02:21.410> for<00:02:21.710> abnormal<00:02:22.370> or<00:02:22.610> precancerous<00:02:23.120> tissue

00:02:23.980 --> 00:02:23.990 
look for abnormal or precancerous tissue

00:02:23.990 --> 00:02:27.340 
look for abnormal or precancerous tissue
changes<00:02:24.910> these<00:02:25.910> precancerous<00:02:26.660> changes<00:02:26.720> or

00:02:27.340 --> 00:02:27.350 
changes these precancerous changes or

00:02:27.350 --> 00:02:29.410 
changes these precancerous changes or
dysplasia<00:02:27.950> are<00:02:28.310> very<00:02:28.640> important<00:02:29.210> to<00:02:29.240> be

00:02:29.410 --> 00:02:29.420 
dysplasia are very important to be

00:02:29.420 --> 00:02:32.020 
dysplasia are very important to be
diagnosed<00:02:29.860> because<00:02:30.860> patients<00:02:31.100> who<00:02:31.430> develop<00:02:31.880> a

00:02:32.020 --> 00:02:32.030 
diagnosed because patients who develop a

00:02:32.030 --> 00:02:33.850 
diagnosed because patients who develop a
condition<00:02:32.270> called<00:02:32.720> high-grade<00:02:33.290> dysplasia

00:02:33.850 --> 00:02:33.860 
condition called high-grade dysplasia

00:02:33.860 --> 00:02:36.550 
condition called high-grade dysplasia
are<00:02:34.190> at<00:02:34.700> significant<00:02:35.480> risk<00:02:35.540> to<00:02:35.840> progress<00:02:36.320> on

00:02:36.550 --> 00:02:36.560 
are at significant risk to progress on

00:02:36.560 --> 00:02:40.480 
are at significant risk to progress on
to<00:02:36.890> esophageal<00:02:37.430> cancer<00:02:38.030> in<00:02:38.680> fact<00:02:39.680> patients<00:02:40.400> in

00:02:40.480 --> 00:02:40.490 
to esophageal cancer in fact patients in

00:02:40.490 --> 00:02:41.920 
to esophageal cancer in fact patients in
the<00:02:40.580> past<00:02:40.850> who<00:02:41.060> have<00:02:41.090> been<00:02:41.300> diagnosed<00:02:41.750> with

00:02:41.920 --> 00:02:41.930 
the past who have been diagnosed with

00:02:41.930 --> 00:02:43.960 
the past who have been diagnosed with
high-grade<00:02:42.380> dysplasia<00:02:43.310> related<00:02:43.880> to

00:02:43.960 --> 00:02:43.970 
high-grade dysplasia related to

00:02:43.970 --> 00:02:46.180 
high-grade dysplasia related to
barrett's<00:02:44.240> oesophagus<00:02:44.840> were<00:02:45.709> advised<00:02:46.040> to

00:02:46.180 --> 00:02:46.190 
barrett's oesophagus were advised to

00:02:46.190 --> 00:02:49.000 
barrett's oesophagus were advised to
undergo<00:02:46.730> an<00:02:46.970> esophageal<00:02:47.750> or<00:02:48.290> a<00:02:48.410> surgical

00:02:49.000 --> 00:02:49.010 
undergo an esophageal or a surgical

00:02:49.010 --> 00:02:51.910 
undergo an esophageal or a surgical
procedure<00:02:49.040> to<00:02:49.760> remove<00:02:49.910> the<00:02:50.300> esophagus<00:02:50.920> now

00:02:51.910 --> 00:02:51.920 
procedure to remove the esophagus now

00:02:51.920 --> 00:02:54.070 
procedure to remove the esophagus now
however<00:02:52.190> other<00:02:52.670> procedures<00:02:53.330> are<00:02:53.510> available

00:02:54.070 --> 00:02:54.080 
however other procedures are available

00:02:54.080 --> 00:02:56.050 
however other procedures are available
to<00:02:54.590> treat<00:02:54.860> high-grade<00:02:55.340> dysplasia<00:02:55.790> in

00:02:56.050 --> 00:02:56.060 
to treat high-grade dysplasia in

00:02:56.060 --> 00:02:58.870 
to treat high-grade dysplasia in
Barrett's<00:02:56.420> esophagus<00:02:57.100> one<00:02:58.100> such<00:02:58.400> procedure

00:02:58.870 --> 00:02:58.880 
Barrett's esophagus one such procedure

00:02:58.880 --> 00:03:01.540 
Barrett's esophagus one such procedure
the<00:02:59.180> halo<00:02:59.510> procedure<00:02:59.990> or<00:03:00.560> halo<00:03:01.010> ablation

00:03:01.540 --> 00:03:01.550 
the halo procedure or halo ablation

00:03:01.550 --> 00:03:04.060 
the halo procedure or halo ablation
technique<00:03:02.000> uses<00:03:02.930> heat<00:03:03.140> energy<00:03:03.410> applied

00:03:04.060 --> 00:03:04.070 
technique uses heat energy applied

00:03:04.070 --> 00:03:06.699 
technique uses heat energy applied
directly<00:03:04.490> to<00:03:04.700> the<00:03:04.850> abnormal<00:03:05.480> tissue<00:03:05.709> this

00:03:06.699 --> 00:03:06.709 
directly to the abnormal tissue this

00:03:06.709 --> 00:03:08.740 
directly to the abnormal tissue this
eradicate<00:03:07.370> the<00:03:07.550> tissue<00:03:07.760> and<00:03:07.910> allows<00:03:08.300> for

00:03:08.740 --> 00:03:08.750 
eradicate the tissue and allows for

00:03:08.750 --> 00:03:11.680 
eradicate the tissue and allows for
regrowth<00:03:09.350> of<00:03:09.380> normal<00:03:09.950> tissue<00:03:10.480> studies<00:03:11.480> have

00:03:11.680 --> 00:03:11.690 
regrowth of normal tissue studies have

00:03:11.690 --> 00:03:14.230 
regrowth of normal tissue studies have
shown<00:03:11.720> that<00:03:11.990> eradication<00:03:12.470> of<00:03:13.240> abnormal

00:03:14.230 --> 00:03:14.240 
shown that eradication of abnormal

00:03:14.240 --> 00:03:16.720 
shown that eradication of abnormal
Barrett's<00:03:14.540> esophagus<00:03:15.200> is<00:03:15.610> successful<00:03:16.610> in

00:03:16.720 --> 00:03:16.730 
Barrett's esophagus is successful in

00:03:16.730 --> 00:03:19.300 
Barrett's esophagus is successful in
ninety<00:03:17.030> percent<00:03:17.180> of<00:03:17.450> the<00:03:17.570> patients<00:03:18.310> this

00:03:19.300 --> 00:03:19.310 
ninety percent of the patients this

00:03:19.310 --> 00:03:21.759 
ninety percent of the patients this
procedure<00:03:19.850> is<00:03:20.090> done<00:03:20.120> during<00:03:20.989> a<00:03:21.080> routine<00:03:21.230> upper

00:03:21.759 --> 00:03:21.769 
procedure is done during a routine upper

00:03:21.769 --> 00:03:24.580 
procedure is done during a routine upper
endoscopy<00:03:22.070> in<00:03:22.610> an<00:03:22.730> outpatient<00:03:23.269> setting<00:03:23.660> post

00:03:24.580 --> 00:03:24.590 
endoscopy in an outpatient setting post

00:03:24.590 --> 00:03:26.590 
endoscopy in an outpatient setting post
procedure<00:03:24.860> some<00:03:25.400> patients<00:03:25.850> may<00:03:25.880> find<00:03:26.269> some

00:03:26.590 --> 00:03:26.600 
procedure some patients may find some

00:03:26.600 --> 00:03:28.570 
procedure some patients may find some
mild<00:03:26.840> chest<00:03:27.260> discomfort<00:03:27.470> or<00:03:27.980> difficulty

00:03:28.570 --> 00:03:28.580 
mild chest discomfort or difficulty

00:03:28.580 --> 00:03:29.680 
mild chest discomfort or difficulty
swallowing<00:03:28.760> but<00:03:29.239> these<00:03:29.390> are<00:03:29.540> usually

00:03:29.680 --> 00:03:29.690 
swallowing but these are usually

00:03:29.690 --> 00:03:32.400 
swallowing but these are usually
controlled<00:03:30.260> easily<00:03:30.709> with<00:03:30.890> medical<00:03:31.280> therapy

00:03:32.400 --> 00:03:32.410 
controlled easily with medical therapy

00:03:32.410 --> 00:03:34.570 
controlled easily with medical therapy
approximately<00:03:33.410> two<00:03:33.440> months<00:03:33.830> after<00:03:34.430> the

00:03:34.570 --> 00:03:34.580 
approximately two months after the

00:03:34.580 --> 00:03:37.390 
approximately two months after the
ablation<00:03:34.850> a<00:03:35.180> repeat<00:03:36.110> endoscopy<00:03:36.800> is<00:03:36.890> used<00:03:37.190> to

00:03:37.390 --> 00:03:37.400 
ablation a repeat endoscopy is used to

00:03:37.400 --> 00:03:39.250 
ablation a repeat endoscopy is used to
assess<00:03:37.700> for<00:03:37.940> any<00:03:38.060> residual<00:03:38.570> Barrett's<00:03:38.959> tissue

00:03:39.250 --> 00:03:39.260 
assess for any residual Barrett's tissue

00:03:39.260 --> 00:03:42.400 
assess for any residual Barrett's tissue
if<00:03:39.650> there<00:03:40.280> is<00:03:40.310> any<00:03:40.850> tissue<00:03:41.330> found<00:03:41.750> a<00:03:41.959> repeat

00:03:42.400 --> 00:03:42.410 
if there is any tissue found a repeat

00:03:42.410 --> 00:03:45.520 
if there is any tissue found a repeat
ablation<00:03:42.860> will<00:03:43.040> be<00:03:43.130> performed<00:03:43.700> I<00:03:44.530> currently

00:03:45.520 --> 00:03:45.530 
ablation will be performed I currently

00:03:45.530 --> 00:03:47.229 
ablation will be performed I currently
am<00:03:45.769> performing<00:03:46.220> the<00:03:46.489> halo<00:03:46.760> ablation

00:03:47.229 --> 00:03:47.239 
am performing the halo ablation

00:03:47.239 --> 00:03:48.820 
am performing the halo ablation
technique<00:03:47.630> for<00:03:47.840> my<00:03:47.989> patients<00:03:48.470> who<00:03:48.500> have

00:03:48.820 --> 00:03:48.830 
technique for my patients who have

00:03:48.830 --> 00:03:50.530 
technique for my patients who have
Barrett's<00:03:49.610> oesophagus<00:03:50.180> with<00:03:50.360> high-grade

00:03:50.530 --> 00:03:50.540 
Barrett's oesophagus with high-grade

00:03:50.540 --> 00:03:53.470 
Barrett's oesophagus with high-grade
dysplasia<00:03:51.140> I<00:03:51.610> encourage<00:03:52.610> all<00:03:52.850> patients<00:03:53.390> who

00:03:53.470 --> 00:03:53.480 
dysplasia I encourage all patients who

00:03:53.480 --> 00:03:55.360 
dysplasia I encourage all patients who
have<00:03:53.690> chronic<00:03:54.019> gastroesophageal<00:03:54.620> reflux

00:03:55.360 --> 00:03:55.370 
have chronic gastroesophageal reflux

00:03:55.370 --> 00:03:57.370 
have chronic gastroesophageal reflux
disease<00:03:55.519> to<00:03:56.330> see<00:03:56.510> their<00:03:56.690> physician<00:03:56.870> and

00:03:57.370 --> 00:03:57.380 
disease to see their physician and

00:03:57.380 --> 00:03:59.860 
disease to see their physician and
assess<00:03:57.799> their<00:03:58.400> risk<00:03:58.670> for<00:03:58.790> any<00:03:59.090> complications

00:03:59.860 --> 00:03:59.870 
assess their risk for any complications

00:03:59.870 --> 00:04:02.830 
assess their risk for any complications
related<00:04:00.290> to<00:04:00.440> reflux

